Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Project Updates and Milestones news
(page 52)
9 December 2025
Topsoe and Carbon Neutral Fuels Collaborate on e-SAF Project with SOEC Technology
Project Starling in the UK will use SOEC technology to produce 25,000 tons of e-SAF annually, aiming for an 89% emissions reduction. Construction starts in 2028, operations by 2031.
9 December 2025
Galp and TotalEnergies Swap Stakes in Namibian Offshore Blocks
Galp swaps 40% of PEL 83 for stakes in PEL 56 and PEL 91, with TotalEnergies assuming operatorship and sharing exploration costs. Approval expected by 2026.
9 December 2025
thyssenkrupp Reports Positive Cash Flow and Strategic Progress in 2024/2025
Order intake rose 15%, sales fell 6%. Adjusted EBIT up 13%. Free cash flow positive for third year. Strategic transformation and efficiency improvements underway.
9 December 2025
OCI Global Q3 2025 Update
OCI sells ammonia business, plans merger with Orascom, and reports financials. Beaumont project nears completion; strategic review yields $11.6B, with $7B distributed to shareholders.
8 December 2025
Air Products and Yara Partner on Low-Emission Ammonia Projects
Projects in the U.S. and Saudi Arabia aim for low-emission ammonia production, with investment decisions by 2026 and completion by 2030.
8 December 2025
Boehringer Ingelheim's JASCAYD® Approved in China for Progressive Pulmonary Fibrosis
JASCAYD® (nerandomilast) gains approval in China for progressive pulmonary fibrosis, offering a new treatment option after five years, based on successful Phase III trials.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
8 December 2025
Roche's Columvi Combo Shows Sustained Survival Benefit in Phase III Study
Columvi with GemOx doubles survival in R/R DLBCL patients, approved in 50+ countries, offering a non-transplant treatment option.
8 December 2025
Fluor JV Completes Second LNG Train for LNG Canada
Fluor and JGC complete Train 2 of LNG Canada, marking the first phase's end. The project emphasizes safety, environmental focus, and Indigenous economic engagement.
8 December 2025
Repsol and HitecVision Merge UK Operations with TotalEnergies in North Sea
The merger forms NEO NEXT+, boosting production to 250,000 barrels/day by 2026, with TotalEnergies holding 47.5% and enhancing operational capabilities. Completion expected in H1 2026.
8 December 2025
TechnipFMC Delivers 100th Subsea 2.0 Tree to Shell
The 100th Subsea 2.0 tree, made in Malaysia, will be used in the Gulf of America. The platform's modular design reduces lead time and enhances efficiency in subsea operations.
8 December 2025
Worley to Build UK's First Cement Carbon Capture Facility
The facility will capture 800,000 tonnes of CO2 annually, aiming for net zero cement production by 2029, supporting UK decarbonization and creating jobs in North Wales.
8 December 2025
Equinor Launches First Hybrid Power Complex
Equinor's hybrid power complex in Brazil combines 140 MW solar and 223 MW wind, enhancing energy stability and cost efficiency. Annual output: 236 GWh, powering 143,000 homes.
8 December 2025
Boehringer Ingelheim Advances Triple-Agonist Peptide for Obesity Treatment
BI 3034701 shows promise in Phase I for obesity treatment, demonstrating safety and weight loss, advancing to mid-stage development.
6 December 2025
Genmab Reports Epcoritamab Trials Show Remission in DLBCL and FL
Epcoritamab shows high response rates in DLBCL and FL trials, with promising results in elderly patients and manageable side effects.
6 December 2025
Protagonist and Takeda: Rusfertide's Long-Term Efficacy in Polycythemia Vera
Rusfertide shows sustained hematocrit control and reduced phlebotomy need in polycythemia vera over 52 weeks, with a consistent safety profile.
6 December 2025
Johnson & Johnson's CARVYKTI® Shows 2.5-Year Remission in Early Myeloma Treatment
CARVYKTI® offers 80% of standard-risk myeloma patients lasting remission after a single infusion, with improved outcomes when used early.
5 December 2025
Johnson & Johnson's INLEXZO™ Shows 74% One-Year Disease-Free Survival in High-Risk NMIBC
New data shows high survival rates and bladder preservation in BCG-unresponsive NMIBC patients using gemcitabine intravesical system, with minimal severe side effects.
5 December 2025
Vulcan Energy Breaks Ground on Geothermal and Lithium Plant in Landau
The plant will provide climate-neutral district heating and lithium for battery production, supporting energy transition and raw material independence in Germany.
5 December 2025
Iberdrola Completes Monopile Installation at Windanker Offshore Wind Farm
The Windanker offshore wind farm's 21 monopile foundations are installed. The project is on track to be operational by 2026, expanding Baltic Sea capacity to over 1,100 MW.
5 December 2025
Equinor Discovers Gas and Condensate in North Sea
Two new gas and condensate finds in the Sleipner area can be developed for Europe using existing infrastructure, enhancing export capacity and profitability with minimal environmental impact.
4 December 2025
RWE wins four Italian CfD projects totalling 68 MW
Four projects totalling 68 MW across Basilicata, Campania and Sicily won CfDs in Italy's FER‑X auction; construction is due to start in 2026.
4 December 2025
UPM Streamlines Portfolio for Growth Focus
UPM plans a joint venture with Sappi to enhance growth, focusing on renewable materials, advanced solutions, and decarbonization, while reviewing its plywood business for value maximization.
4 December 2025
Equinor Extends Norne's Lifespan with Verdande Development
Verdande subsea field starts production, extending Norne FPSO's life. Developed swiftly, it boosts resource recovery and supports the Norwegian supplier industry with over NOK 6 billion investment.
4 December 2025
Ørsted's Borkum Riffgrund 3 Offshore Wind Farm in Germany Begins Power Production
Borkum Riffgrund 3 delivers first power to Germany's grid, aiding decarbonization via CPPAs. Full commissioning expected Q1 2026.
3 December 2025
FDA Expands Approval for Lilly's Jaypirca in CLL/SLL Treatment
FDA approves Jaypirca for CLL/SLL patients previously treated with covalent BTK inhibitors, offering a new treatment option with proven efficacy and safety.
3 December 2025
Umicore: Slight Increase in Blood Lead Levels Near Hoboken Site
Average blood lead levels near the site rose but stayed within norms. Participation in tests decreased. Umicore continues environmental efforts and encourages more children to join studies.
2 December 2025
Johnson & Johnson's IMAAVY® (nipocalimab) Approved by European Commission for Generalised Myasthenia Gravis
IMAAVY® (nipocalimab) gains EU approval for gMG, showing sustained disease control in adults and adolescents, with consistent safety and tolerability.
2 December 2025
TotalEnergies Clarifies Mozambique LNG Project Financing
Mozambique LNG partners replace UKEF and Atradius with additional equity after force majeure. 90% of lenders remain committed. Concerns raised over human rights reports in Cabo Delgado.
2 December 2025
Eni Advances Congo LNG Phase 2 Ahead of Schedule
Phase 2 of Congo LNG starts early with Nguya FLNG, boosting capacity to 3 MTPA. Local engagement and innovation drive efficiency and decarbonization.
1 December 2025
ORLEN Secures URE Auction for Baltic East Offshore Wind Project
Baltic East wins URE auction, securing CfD support for 25 years. First electricity expected by 2032, enhancing Poland's energy security and supporting the zero-carbon transition.
← Previous
Next →
